HIV / AIDS in the News

Merck Expands Beyond Oncology With New HIV RSV Allergy And Rare Disease Bets - Yahoo Finance

 

Merck Expands Beyond Oncology With New HIV RSV Allergy And Rare Disease Bets - Yahoo Finance UK

 

A5332 - Mechanistic Substudy of REPRIEVE - UCLA Health

 

The Bangui operation: A story of blood, science and biomedical exploitation - Medical Xpress

 

TC Health and Wellness Foundation sounds alarm on rising HIV cases - Turks and Caicos Weekly News

 

Indiana to end HIV outreach program amid federal funding cuts - WSBT

 

In Eswatini, an HIV Breakthrough Delivered - Angels in Medicine

 

Indiana ending statewide HIV outreach and testing program - 103.9 Wayne FM

 

FDA Advances Therapies for HIV, Hepatitis B and MASH - hepmag.com

 

FDA Advances Therapies for HIV, Hepatitis B and MASH - poz.com

 

DR Congo: Sacred Heart of Jesus Sisters serving people with HIV/AIDS - Herald Malaysia Online

 

Gilead Advances HIV And Oncology Pipeline As Shares Trade Below Targets - simplywall.st

 

Bictegravir/Lenacapavir Single-Tablet HIV Regimen Under FDA Review - Infectious Disease Advisor

 

FDA Alert: Infectious Diseases Drug News Roundup 2026 - Infectious Disease Advisor

 

Diagnostic Challenges in Disseminated Mycobacterium szulgai Infection: A Case Report in the Setting of Advanced HIV Infection - Cureus

 

FDA Accepts New Drug Application for BIC/LEN - Infectious Disease Special Edition

 

TheBody: RIP Loreen Willenberg, who gave her HIV-proof body to science and her heart to the community - European AIDS Treatment Group

 

Colombia Wins International Litigation to Produce Generics of a Drug Used to Treat HIV - ColombiaOne.com

 

Want to Provide Latinos With Better HIV and Hepatitis Services? NaLa Knows How! - poz.com

 

Infectious Disease Special Edition: Immunomodulators in patients living with HIV - European AIDS Treatment Group

 

amfAR: Best supporting actors: Other immune cells shaping the future of HIV research - European AIDS Treatment Group

 

FDA Approves Once-Daily Idvynso Tablet for Treating HIV - HealthDay

 

Pinch of Salt: Help make up for money stolen from HIV/AIDS CARE Center - Long Beach Press-Telegram

 

Trial date set for Butler County man accused of having sex without disclosing HIV status - WLWT

 

AMJC: CAR therapies could offer new HBV, HIV treatments - European AIDS Treatment Group

 

Karolinska Institutet: Vaccine strategy induces broadly neutralising HIV antibodies - European AIDS Treatment Group

 

[Statement] MSF: Gilead stockholders: Demand Gilead sell HIV prevention drug to those who need it - European AIDS Treatment Group

 

[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir - European AIDS Treatment Group

 

The New Frontiers of Aging - Mother Jones

 

Gilead won’t sell MSF its HIV drug. Its shareholders should ask why - Doctors Without Borders